NCT00559819

Brief Summary

The proposed study will validate and determine sensitivity of our new driving simulator, created to evaluate driving ability in a related study to show similar driving performance between patients on chronic opioid treatment and a control group. Although the commercial version of the simulator has been validated for certain populations and certain measures, these require re-calibration for our own clinical study. The investigators propose a prospective randomized clinical trial to evaluate driving skills under alcohol consumption using a driving simulator. Two groups of study subjects will be utilized, with the majority (80%) receiving alcohol and placebo at different times. A smaller set of study subjects (20%) will be given placebo on both trials to evaluate learning effects and placebo blinding effectiveness. Each group will take the driving test at three time points: once as a baseline at the beginning of the study, once after the 1st dosing of the placebo and again after dosing two of the alcohol or placebo beverage. This information will allow us to evaluate driving ability under other potentially impairing conditions such as opioid usage.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Feb 2008

Longer than P75 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 14, 2007

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 16, 2007

Completed
3 months until next milestone

Study Start

First participant enrolled

February 1, 2008

Completed
14.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2022

Completed
Last Updated

December 14, 2022

Status Verified

December 1, 2022

Enrollment Period

14.1 years

First QC Date

November 14, 2007

Last Update Submit

December 12, 2022

Conditions

Keywords

AlcoholDrivingImpairment

Outcome Measures

Primary Outcomes (1)

  • Weaving (Standard Deviation of Lateral Deviation)

    6 h

Secondary Outcomes (1)

  • Reaction Time (RT) to unexpected stimuli, and number of accidents

    6 h

Study Arms (2)

Alcohol

ACTIVE COMPARATOR

Alcohol

Drug: Alcohol

Placebo

PLACEBO COMPARATOR

Orange juice

Drug: placebo

Interventions

Placebo (orange juice), same volume as alcohol

Also known as: Orange Juice
Placebo

Dose with Alcohol (Vodka) to make blood alcohol concentration 0.08%

Also known as: Vodka
Alcohol

Eligibility Criteria

Age21 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Legal drinking age (=\> 21).
  • Moderate alcohol consumption
  • Defined as: at least 1 unit per week but less than 20 units per week. (unit = 12 oz. beer or equivalent).
  • Current driver's license.
  • Subjects can understand and communicate in English.

You may not qualify if:

  • Known alcoholic or drug abuser.
  • Alcohol naïve.
  • Use of medications that may be aggravated (or contraindicated) by alcohol.
  • Pregnant or breast feeding.
  • Younger than 21 years or older than 80 years.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rush University Medical Center

Chicago, Illinois, 60612, United States

Location

MeSH Terms

Interventions

Ethanol

Intervention Hierarchy (Ancestors)

AlcoholsOrganic Chemicals

Study Officials

  • Asokumar Buvanendran, MD

    Rush University Medical Center

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Coordinator

Study Record Dates

First Submitted

November 14, 2007

First Posted

November 16, 2007

Study Start

February 1, 2008

Primary Completion

March 1, 2022

Study Completion

July 1, 2022

Last Updated

December 14, 2022

Record last verified: 2022-12

Locations